Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10493503rdf:typepubmed:Citationlld:pubmed
pubmed-article:10493503lifeskim:mentionsumls-concept:C0040132lld:lifeskim
pubmed-article:10493503lifeskim:mentionsumls-concept:C0205312lld:lifeskim
pubmed-article:10493503lifeskim:mentionsumls-concept:C0205696lld:lifeskim
pubmed-article:10493503lifeskim:mentionsumls-concept:C0035696lld:lifeskim
pubmed-article:10493503lifeskim:mentionsumls-concept:C0443286lld:lifeskim
pubmed-article:10493503lifeskim:mentionsumls-concept:C0011900lld:lifeskim
pubmed-article:10493503lifeskim:mentionsumls-concept:C1555029lld:lifeskim
pubmed-article:10493503lifeskim:mentionsumls-concept:C1524075lld:lifeskim
pubmed-article:10493503lifeskim:mentionsumls-concept:C0445204lld:lifeskim
pubmed-article:10493503lifeskim:mentionsumls-concept:C0392762lld:lifeskim
pubmed-article:10493503lifeskim:mentionsumls-concept:C0909229lld:lifeskim
pubmed-article:10493503lifeskim:mentionsumls-concept:C0337112lld:lifeskim
pubmed-article:10493503pubmed:issue18lld:pubmed
pubmed-article:10493503pubmed:dateCreated1999-10-8lld:pubmed
pubmed-article:10493503pubmed:abstractTextThe restricted expression of oncofetal fibronectin (onfFN) mRNA in thyroid papillary and anaplastic carcinomas was recently reported. In this study, we measured the copy number of onfFN mRNA in RNAs extracted from fine needle aspiration biopsies by real-time quantitative reverse transcription-PCR using thyroglobulin mRNA as an internal control. By measuring the onfFN:thyroglobulin mRNA ratio, preoperative aspirates from 31 papillary carcinomas and an anaplastic carcinoma can be distinguished from those from 5 adenomatous goiters, 5 follicular adenomas, and 4 follicular carcinomas. Thus, quantification of onfFN by real-time quantitative reverse transcription-PCR may be useful for the preoperative diagnosis of papillary and anaplastic carcinomas.lld:pubmed
pubmed-article:10493503pubmed:languageenglld:pubmed
pubmed-article:10493503pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10493503pubmed:citationSubsetIMlld:pubmed
pubmed-article:10493503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10493503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10493503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10493503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10493503pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10493503pubmed:statusMEDLINElld:pubmed
pubmed-article:10493503pubmed:monthSeplld:pubmed
pubmed-article:10493503pubmed:issn0008-5472lld:pubmed
pubmed-article:10493503pubmed:authorpubmed-author:TakanoTTlld:pubmed
pubmed-article:10493503pubmed:authorpubmed-author:AminoNNlld:pubmed
pubmed-article:10493503pubmed:authorpubmed-author:KumaKKlld:pubmed
pubmed-article:10493503pubmed:authorpubmed-author:MatsuzukaFFlld:pubmed
pubmed-article:10493503pubmed:authorpubmed-author:MiyauchiAAlld:pubmed
pubmed-article:10493503pubmed:authorpubmed-author:YokozawaTTlld:pubmed
pubmed-article:10493503pubmed:authorpubmed-author:MaedaIIlld:pubmed
pubmed-article:10493503pubmed:issnTypePrintlld:pubmed
pubmed-article:10493503pubmed:day15lld:pubmed
pubmed-article:10493503pubmed:volume59lld:pubmed
pubmed-article:10493503pubmed:ownerNLMlld:pubmed
pubmed-article:10493503pubmed:authorsCompleteYlld:pubmed
pubmed-article:10493503pubmed:pagination4542-5lld:pubmed
pubmed-article:10493503pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10493503pubmed:meshHeadingpubmed-meshheading:10493503...lld:pubmed
pubmed-article:10493503pubmed:meshHeadingpubmed-meshheading:10493503...lld:pubmed
pubmed-article:10493503pubmed:meshHeadingpubmed-meshheading:10493503...lld:pubmed
pubmed-article:10493503pubmed:meshHeadingpubmed-meshheading:10493503...lld:pubmed
pubmed-article:10493503pubmed:meshHeadingpubmed-meshheading:10493503...lld:pubmed
pubmed-article:10493503pubmed:meshHeadingpubmed-meshheading:10493503...lld:pubmed
pubmed-article:10493503pubmed:meshHeadingpubmed-meshheading:10493503...lld:pubmed
pubmed-article:10493503pubmed:meshHeadingpubmed-meshheading:10493503...lld:pubmed
pubmed-article:10493503pubmed:meshHeadingpubmed-meshheading:10493503...lld:pubmed
pubmed-article:10493503pubmed:meshHeadingpubmed-meshheading:10493503...lld:pubmed
pubmed-article:10493503pubmed:meshHeadingpubmed-meshheading:10493503...lld:pubmed
pubmed-article:10493503pubmed:meshHeadingpubmed-meshheading:10493503...lld:pubmed
pubmed-article:10493503pubmed:year1999lld:pubmed
pubmed-article:10493503pubmed:articleTitlePreoperative diagnosis of thyroid papillary and anaplastic carcinomas by real-time quantitative reverse transcription-polymerase chain reaction of oncofetal fibronectin messenger RNA.lld:pubmed
pubmed-article:10493503pubmed:affiliationDepartment of Laboratory Medicine, Osaka University Medical School, Suita, Japan.lld:pubmed
pubmed-article:10493503pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10493503pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10493503lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10493503lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10493503lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10493503lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10493503lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10493503lld:pubmed